drugset / Trial / NCT05366504

LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment

NCT05366504

RandomizedParallel-groupQuadruple-blindTreatment

Summary

We designed a double blind randomized sham-controlled trial in order to investigate and compare the treatment efficacy of LiST plus PRP intracorporeal injection vs LiST plus placebo (normal saline intracorporeal injection) in men with moderate and mild to moderate vasculogenic ED, as measured by IIEF-EF.

Timeline

Start
2022-09
Primary completion
2023-12
Completion
2024-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified Other

Indications